Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
| Autor: | Cohen, Jeffrey A, Coles, Alasdair J, Arnold, Douglas L, Confavreux, Christian, Fox, Edward J, Hartung, Hans-Peter, Havrdova, Eva, Selmaj, Krzysztof W, Weiner, Howard L, Fisher, Elizabeth, Brinar, Vesna V, Giovannoni, Gavin, Stojanovic, Miroslav, Ertik, Bella I, Lake, Stephen L, Margolin, David H, Panzara, Michael A, Compston, D Alastair S |
|---|---|
| Zdroj: | In The Lancet 24-30 November 2012 380(9856):1819-1828 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|